Last reviewed · How we verify
William Sikov MD — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
0 Phase 3
1 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
Therapeutic area mix
- Oncology · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Assistance Publique - Hôpitaux de Paris · 1 shared drug class
- Brenda Cooper, MD · 1 shared drug class
- Bristol-Myers Squibb · 1 shared drug class
- EMS · 1 shared drug class
- GERCOR - Multidisciplinary Oncology Cooperative Group · 1 shared drug class
- Glycotope GmbH · 1 shared drug class
- Grace Therapeutics Inc. · 1 shared drug class
- Ahn-Gook Pharmaceuticals Co.,Ltd · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for William Sikov MD:
- William Sikov MD pipeline updates — RSS
- William Sikov MD pipeline updates — Atom
- William Sikov MD pipeline updates — JSON
Cite this brief
Drug Landscape (2026). William Sikov MD — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/william-sikov-md. Accessed 2026-05-16.